Triple

Target entity: U.S. Food and Drug Administration
Context triple: [ICH Q9 Quality Risk Management, regionallyImplementedBy, U.S. Food and Drug Administration]

• A. Food and Drug Administration chosen
  The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
• B. Center for Biologics Evaluation and Research
  The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
• C. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• D. Office of Regulatory Affairs
  The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
• E. FDA CFSAN
  FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.